Syneos Health, Inc.

Syneos Health, Inc. is a leading global biopharmaceutical solutions organization that provides fully integrated services through its Contract Research Organization and Contract Commercial Organization segments. Formed by the 2018 merger of INC Research and inVentiv Health, the company supports the entire clinical-to-commercial spectrum, including clinical development, regulatory consulting, and medical affairs. Headquartered in Morrisville, North Carolina, it utilizes AI-enabled platforms to accelerate the delivery of therapies and has contributed to the development of the vast majority of novel oncology drugs. Operating in over 110 countries with a workforce of approximately 25,000 professionals, Syneos Health was taken private in 2023 by a consortium led by Elliott Investment Management.